JCR Pharmaceuticals Co., Ltd. (TYO:4552)

JCR Pharmaceuticals Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 29, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	63,083	69,288	58,963	107,204	176,306	279,312
Market Cap Growth	-26.35%	17.51%	-45.00%	-39.19%	-36.88%	-36.97%
Enterprise Value	103,385	106,682	76,238	112,497	181,176	266,306
Last Close Price	517.00	568.00	468.52	804.56	1298.80	2051.26

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 29, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	28.95	31.81	-	19.47	46.74	19.25
Forward PE	124.70	39.18	18.68	15.47	25.97	25.23
PS Ratio	1.56	1.72	1.78	2.50	5.13	5.47
PB Ratio	1.33	1.46	1.24	1.90	3.36	5.47
P/TBV Ratio	1.42	1.56	1.33	2.04	3.63	5.83
P/FCF Ratio	-	-	-	13.77	-	-
P/OCF Ratio	-	-	-	11.51	-	30.07
PEG Ratio	-	2.72	2.72	2.72	2.72	1.84

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 29, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	2.56	2.65	2.31	2.62	5.28	5.21
EV/EBITDA Ratio	36.87	35.70	-	10.49	25.98	12.17
EV/EBIT Ratio	-	247.52	-	14.94	36.40	13.36
EV/FCF Ratio	-	-	-	14.45	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 29, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	1.14	1.14	0.80	0.41	0.44	0.35
Debt / EBITDA Ratio	18.04	18.04	-	2.17	3.27	0.83
Debt / FCF Ratio	-	-	-	2.99	-	-
Net Debt / Equity Ratio	0.84	0.84	0.52	0.08	0.18	-0.25
Net Debt / EBITDA Ratio	13.35	13.35	-8.20	0.42	1.37	-0.59
Net Debt / FCF Ratio	-3.45	-3.45	-1.62	0.58	-0.72	6.30
Asset Turnover	0.38	0.38	0.32	0.44	0.36	0.60
Inventory Turnover	0.44	0.44	0.51	0.59	0.54	0.74
Quick Ratio	0.59	0.59	0.58	1.12	0.68	1.11
Current Ratio	1.17	1.17	1.18	1.91	1.34	1.48
Return on Equity (ROE)	4.64%	4.64%	-8.44%	10.17%	7.32%	32.39%
Return on Assets (ROA)	0.25%	0.25%	-3.87%	4.78%	3.24%	14.58%
Return on Invested Capital (ROIC)	0.34%	0.37%	-9.59%	9.36%	6.96%	43.48%
Return on Capital Employed (ROCE)	0.70%	0.70%	-10.50%	10.40%	8.40%	36.20%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 29, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	3.45%	3.14%	-7.56%	5.14%	2.14%	5.19%
FCF Yield	-18.33%	-16.69%	-26.07%	7.26%	-7.46%	-0.73%
Dividend Yield	3.87%	3.52%	4.27%	2.49%	1.54%	0.97%
Payout Ratio	112.08%	112.07%	-	45.40%	72.61%	14.95%
Buyback Yield / Dilution	1.47%	1.47%	1.25%	-0.45%	-0.51%	-0.06%
Total Shareholder Return	5.33%	4.99%	5.52%	2.04%	1.03%	0.91%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error